跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NEOATRICON 4,5 MG/ML SOLUCION PARA PERFUSION - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
NEOATRICON 4,5 MG/ML SOLUCION PARA PERFUSION
Approved
STANDARD
NEOATRICON 4,5 MG/ML SOLUCION PARA PERFUSION
Brepco Biopharma Limited
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Apr 9, 2025
Approval ID
58bd028d9da677b6
Company
Brepco Biopharma Limited
Type
Standard
Approval Details
Approval Id
58bd028d9da677b6
Drug Cima Aemps Name
NEOATRICON 4,5 MG/ML SOLUCION PARA PERFUSION
Register Number
1241804002
Holder Company Name
Brepco Biopharma Limited
Marketing Company Name
Euromed Pharma Spain S.L.
Holder Company Detail Path
/organization/brepco-biopharma-limited
Authorization Date
2025-04-09
Dosage Form
SOLUCIÓN PARA PERFUSIÓN
Dose
4,5 mg/ml
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Brepco Biopharma Limited
Company Detail Path
/organization/brepco-biopharma-limited
Company Information
Pharmaceutical Company Name
BREPCO BIOPHARMA LIMITED
Country Name
Ireland
City Name
dublin,country_ie
Address
SUITE ONE THE AVENUE BEACON COUR
Active Ingredients
DOPAMINA HIDROCLORURO
225 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Apr 9, 2025
Approval ID
58bd028d9da677b6
Type
Standard
Back to CIMA-AEMPS Approvals
